Avulux
Private
Medical device company developing clinically-proven precision light-filtering lenses for people living with migraine and light sensitivity. Received the first FDA De Novo authorization for a lens classification targeting migraine-associated light sensitivity.
Company Info
Upcoming Milestones & Key Dates
2026-08
Regulatory
FDA De Novo marketing authorization granted
Clinical Development Pipeline
Avulux Light-Filtering Lens
Target: Light spectrum filteringRecent News
No recent news updates available for this company.